ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer
Purpose Cathepsin and plasmin may favor cancer cell invasion degrading extracellular matrix. Plasmin formation from plasminogen is regulated by plasminogen activator inhibitor type-1 (PAI-1). ARNTL2 activates the promoters of the PAI-1 gene, officially called SERPINE1, driving the circadian variatio...
Gespeichert in:
Veröffentlicht in: | Journal of cancer research and clinical oncology 2012-03, Vol.138 (3), p.501-511 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
Cathepsin and plasmin may favor cancer cell invasion degrading extracellular matrix. Plasmin formation from plasminogen is regulated by plasminogen activator inhibitor type-1 (PAI-1).
ARNTL2
activates the promoters of the PAI-1 gene, officially called
SERPINE1,
driving the circadian variation in circulating PAI-1 levels.
Methods
We evaluated
ARNTL2
and
SERPINE1
expression in 50 colorectal cancer specimens and adjacent normal tissue and in colon cancer cell lines.
Results
We found up-regulation of
ARNTL2
(
P
= 0.004) and
SERPINE1
(
P
= 0.002) in tumor tissue. A statistically significant association was found between high
ARNTL2
mRNA levels and vascular invasion (
P
|
---|---|
ISSN: | 0171-5216 1432-1335 |
DOI: | 10.1007/s00432-011-1126-6 |